Also, genes that code for
receptor tyrosine kinases, a family of
receptors on the
surface of
cells, may rearrange to form multiple
distinct gene fusion partners, as evidenced in an article by Kulkarni, et al, on a translational study involving a patient who developed a BRAF fusion following treatment with a BRAF inhibitor1.